Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

August 01, 2006
132332
Cancer, Cancer - Breast
Grace Makari-Judson, MD
Baystate Breast and Wellness Center, 100 Wason Avenue, 3rd Floor, Springfield, MA
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. It is not yet known whether letrozole is more effective than a placebo in treating patients with hormone receptor-positive breast cancer.

PURPOSE: This randomized phase III trial is studying letrozole to see how well it works compared with a placebo in treating postmenopausal women who have received hormone therapy for hormone receptor-positive breast cancer.
Ages Eligible for Study: 18 Years to 120 Years (Adult, Older Adult)
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Active
Interventional (Clinical Trial), Randomized
3
Ruth Barham
413-794-3186